Laman Utama1PG • FRA
add
Aker Biomarine ASA
Tutup sebelumnya
€5.56
Julat hari
€5.63 - €5.63
Julat tahun
€3.80 - €8.91
Bilangan Purata
39.00
Nisbah P/E
-
Hasil dividen
-
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Mac 2025info | Perubahan T/T |
|---|---|---|
Hasil | 50.80J | 4.74% |
Perbelanjaan pengendalian | 20.20J | -11.79% |
Pendapatan bersih | -3.10J | 73.95% |
Margin untung bersih | -6.10 | 75.14% |
Pendapatan bagi setiap syer | — | — |
EBITDA | 4.10J | -57.73% |
Kadar cukai berkesan | -42.86% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 16.00J | -50.00% |
Jumlah aset | 389.60J | -52.11% |
Jumlah liabiliti | 219.00J | -52.27% |
Jumlah ekuiti | 170.60J | — |
Syer tertunggak | 87.69J | — |
Harga kepada buku | 2.85 | — |
Pulangan pada aset | -0.13% | — |
Pulangan pada modal | -0.15% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -3.10J | 73.95% |
Tunai daripada operasi | -10.90J | -626.67% |
Tunai daripada pelaburan | -2.60J | 43.48% |
Tunai daripada pembiayaan | 14.50J | 38.10% |
Perubahan bersih dalam tunai | 1.00J | -77.27% |
Aliran tunai bebas | -11.14J | -474.37% |
Perihal
Aker BioMarine is a leading human health and nutrition innovator that develops krill-derived products for consumer health and nutrition. Krill is a natural, powerful, and health-promoting source of nutrients from the pristine waters of Antarctica, and Aker BioMarine has a unique position in its industry. The ingredient portfolio consists of Superba Krill Oil, Lysoveta, FloraMarine, and PL+, as well as the consumer brand, Kori Krill. The innovative approach also extends into the spin-offs AION and Understory. Aker BioMarine is listed on the Oslo Stock Exchange. Wikipedia
Diasaskan
2006
Tapak web
Pekerja
249
